Annual EBITDA
-$64.20 M
+$29.42 M+31.43%
31 December 2023
Summary:
Assembly Biosciences annual earnings before interest, taxes, depreciation & amortization is currently -$64.20 million, with the most recent change of +$29.42 million (+31.43%) on 31 December 2023. During the last 3 years, it has fallen by -$111.00 thousand (-0.17%). ASMB annual EBITDA is now -1826.25% below its all-time high of -$3.33 million, reached on 31 December 2009.ASMB EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$10.92 M
+$1.25 M+10.25%
30 September 2024
Summary:
Assembly Biosciences quarterly earnings before interest, taxes, depreciation & amortization is currently -$10.92 million, with the most recent change of +$1.25 million (+10.25%) on 30 September 2024. Over the past year, it has increased by +$4.01 million (+26.85%). ASMB quarterly EBITDA is now -263.01% below its all-time high of $6.70 million, reached on 30 June 2020.ASMB Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$46.26 M
+$4.01 M+7.98%
30 September 2024
Summary:
Assembly Biosciences TTM earnings before interest, taxes, depreciation & amortization is currently -$46.26 million, with the most recent change of +$4.01 million (+7.98%) on 30 September 2024. Over the past year, it has increased by +$28.32 million (+37.98%). ASMB TTM EBITDA is now -3821.17% below its all-time high of -$1.18 million, reached on 31 March 2009.ASMB TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ASMB EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.4% | +26.9% | +38.0% |
| 3 y3 years | -0.2% | +41.8% | +57.5% |
| 5 y5 years | +30.3% | +57.8% | +53.6% |
ASMB EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -0.2% | +31.4% | -2.1% | +55.3% | at high | +57.5% |
| 5 y | 5 years | -0.2% | +37.2% | -263.0% | +72.2% | at high | +57.5% |
| alltime | all time | -1826.3% | +37.2% | -263.0% | +72.2% | -3821.2% | +57.5% |
Assembly Biosciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$10.92 M(-10.3%) | -$46.26 M(-8.0%) |
| June 2024 | - | -$12.17 M(+13.8%) | -$50.27 M(-9.4%) |
| Mar 2024 | - | -$10.70 M(-14.2%) | -$55.46 M(-13.6%) |
| Dec 2023 | -$64.20 M(-31.4%) | -$12.47 M(-16.5%) | -$64.20 M(-13.9%) |
| Sept 2023 | - | -$14.93 M(-14.0%) | -$74.58 M(-10.1%) |
| June 2023 | - | -$17.36 M(-10.7%) | -$82.92 M(-7.9%) |
| Mar 2023 | - | -$19.43 M(-15.0%) | -$90.01 M(-3.9%) |
| Dec 2022 | -$93.62 M(+3.3%) | -$22.85 M(-1.8%) | -$93.62 M(+1.9%) |
| Sept 2022 | - | -$23.27 M(-4.9%) | -$91.89 M(+5.2%) |
| June 2022 | - | -$24.45 M(+6.1%) | -$87.38 M(+1.0%) |
| Mar 2022 | - | -$23.04 M(+9.0%) | -$86.47 M(-4.5%) |
| Dec 2021 | -$90.58 M(+41.3%) | -$21.13 M(+12.7%) | -$90.58 M(-16.7%) |
| Sept 2021 | - | -$18.76 M(-20.3%) | -$108.78 M(+15.8%) |
| June 2021 | - | -$23.55 M(-13.3%) | -$93.90 M(+47.5%) |
| Mar 2021 | - | -$27.15 M(-31.0%) | -$63.66 M(-0.7%) |
| Dec 2020 | -$64.08 M(-37.3%) | -$39.33 M(+913.9%) | -$64.08 M(+20.2%) |
| Sept 2020 | - | -$3.88 M(-157.9%) | -$53.32 M(-29.2%) |
| June 2020 | - | $6.70 M(-124.3%) | -$75.32 M(-25.9%) |
| Mar 2020 | - | -$27.58 M(-3.5%) | -$101.60 M(-0.6%) |
| Dec 2019 | -$102.22 M(+11.0%) | -$28.57 M(+10.4%) | -$102.22 M(+2.4%) |
| Sept 2019 | - | -$25.88 M(+32.2%) | -$99.80 M(+3.6%) |
| June 2019 | - | -$19.57 M(-30.6%) | -$96.34 M(-7.2%) |
| Mar 2019 | - | -$28.20 M(+7.8%) | -$103.79 M(+12.7%) |
| Dec 2018 | -$92.09 M(+77.1%) | -$26.15 M(+16.7%) | -$92.09 M(+17.9%) |
| Sept 2018 | - | -$22.41 M(-17.1%) | -$78.13 M(+14.7%) |
| June 2018 | - | -$27.02 M(+63.7%) | -$68.12 M(+24.7%) |
| Mar 2018 | - | -$16.50 M(+35.4%) | -$54.61 M(+5.0%) |
| Dec 2017 | -$52.01 M(+15.1%) | -$12.19 M(-1.8%) | -$52.01 M(+0.7%) |
| Sept 2017 | - | -$12.41 M(-8.2%) | -$51.67 M(+1.5%) |
| June 2017 | - | -$13.52 M(-2.7%) | -$50.92 M(+6.4%) |
| Mar 2017 | - | -$13.90 M(+17.4%) | -$47.84 M(+5.8%) |
| Dec 2016 | -$45.20 M | -$11.84 M(+1.6%) | -$45.20 M(+8.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2016 | - | -$11.66 M(+11.7%) | -$41.51 M(+12.3%) |
| June 2016 | - | -$10.44 M(-7.3%) | -$36.96 M(+9.8%) |
| Mar 2016 | - | -$11.26 M(+38.0%) | -$33.66 M(+13.8%) |
| Dec 2015 | -$29.59 M(+23.6%) | -$8.16 M(+14.8%) | -$29.59 M(+6.8%) |
| Sept 2015 | - | -$7.10 M(-0.5%) | -$27.71 M(-12.5%) |
| June 2015 | - | -$7.14 M(-0.7%) | -$31.66 M(+17.1%) |
| Mar 2015 | - | -$7.19 M(+14.5%) | -$27.03 M(+12.9%) |
| Dec 2014 | -$23.95 M(+22.2%) | -$6.28 M(-43.2%) | -$23.95 M(+0.8%) |
| Sept 2014 | - | -$11.05 M(+341.3%) | -$23.76 M(+34.7%) |
| June 2014 | - | -$2.51 M(-39.0%) | -$17.64 M(-11.5%) |
| Mar 2014 | - | -$4.11 M(-32.6%) | -$19.94 M(+2.0%) |
| Dec 2013 | -$19.60 M(-20.9%) | -$6.09 M(+23.5%) | -$19.55 M(+13.3%) |
| Sept 2013 | - | -$4.93 M(+2.6%) | -$17.25 M(-2.4%) |
| June 2013 | - | -$4.81 M(+29.2%) | -$17.67 M(-13.1%) |
| Mar 2013 | - | -$3.72 M(-1.8%) | -$20.33 M(-18.0%) |
| Dec 2012 | -$24.79 M(-26.9%) | -$3.79 M(-29.2%) | -$24.79 M(-37.7%) |
| Sept 2012 | - | -$5.35 M(-28.3%) | -$39.81 M(-0.5%) |
| June 2012 | - | -$7.47 M(-8.6%) | -$40.00 M(+1.4%) |
| Mar 2012 | - | -$8.17 M(-56.6%) | -$39.45 M(+16.2%) |
| Dec 2011 | -$33.92 M(+614.4%) | -$18.81 M(+239.2%) | -$33.95 M(+85.8%) |
| Sept 2011 | - | -$5.54 M(-19.9%) | -$18.27 M(+38.0%) |
| June 2011 | - | -$6.92 M(+158.5%) | -$13.24 M(+70.6%) |
| Mar 2011 | - | -$2.68 M(-14.5%) | -$7.76 M(+43.7%) |
| Dec 2010 | -$4.75 M(+42.5%) | -$3.13 M(+515.0%) | -$5.40 M(+62.7%) |
| Sept 2010 | - | -$509.10 K(-64.7%) | -$3.32 M(-5.8%) |
| June 2010 | - | -$1.44 M(+356.0%) | -$3.52 M(+42.7%) |
| Mar 2010 | - | -$316.30 K(-69.9%) | -$2.47 M(-25.9%) |
| Dec 2009 | -$3.33 M(-53.5%) | -$1.05 M(+47.4%) | -$3.33 M(+46.1%) |
| Sept 2009 | - | -$713.00 K(+83.4%) | -$2.28 M(+45.5%) |
| June 2009 | - | -$388.80 K(-67.0%) | -$1.57 M(+33.0%) |
| Mar 2009 | - | -$1.18 M | -$1.18 M |
| Dec 2008 | -$7.16 M | - | - |
FAQ
- What is Assembly Biosciences annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Assembly Biosciences?
- What is Assembly Biosciences annual EBITDA year-on-year change?
- What is Assembly Biosciences quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Assembly Biosciences?
- What is Assembly Biosciences quarterly EBITDA year-on-year change?
- What is Assembly Biosciences TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Assembly Biosciences?
- What is Assembly Biosciences TTM EBITDA year-on-year change?
What is Assembly Biosciences annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ASMB is -$64.20 M
What is the all time high annual EBITDA for Assembly Biosciences?
Assembly Biosciences all-time high annual earnings before interest, taxes, depreciation & amortization is -$3.33 M
What is Assembly Biosciences annual EBITDA year-on-year change?
Over the past year, ASMB annual earnings before interest, taxes, depreciation & amortization has changed by +$29.42 M (+31.43%)
What is Assembly Biosciences quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ASMB is -$10.92 M
What is the all time high quarterly EBITDA for Assembly Biosciences?
Assembly Biosciences all-time high quarterly earnings before interest, taxes, depreciation & amortization is $6.70 M
What is Assembly Biosciences quarterly EBITDA year-on-year change?
Over the past year, ASMB quarterly earnings before interest, taxes, depreciation & amortization has changed by +$4.01 M (+26.85%)
What is Assembly Biosciences TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ASMB is -$46.26 M
What is the all time high TTM EBITDA for Assembly Biosciences?
Assembly Biosciences all-time high TTM earnings before interest, taxes, depreciation & amortization is -$1.18 M
What is Assembly Biosciences TTM EBITDA year-on-year change?
Over the past year, ASMB TTM earnings before interest, taxes, depreciation & amortization has changed by +$28.32 M (+37.98%)